Literature DB >> 2117355

Osteochondritis dissecans of the knee: value of MR imaging in determining lesion stability and the presence of articular cartilage defects.

A A De Smet1, D R Fisher, B K Graf, R H Lange.   

Abstract

Osteochondritis dissecans is a lesion of articular surfaces that is of uncertain etiology. These lesions are seen on radiographs as a bony defect or fragmentation of the subchondral bone. A bony defect may be an actual surface hole or the defect may be filled with fibrous tissue or fibrocartilage. Similarly, the apparent bone fragments may be only partially attached so they are unstable and prone to displacement or they may be firmly attached with fibrous tissue. Knowledge of fragment stability and the presence of an articular cartilage defect is useful in deciding on treatment. This information cannot be determined on plain films or clinical examination. We correlated MR examinations with arthroscopic findings in 21 patients with osteochondritis dissecans of the knee to see if MR imaging could be used to predict lesion stability and articular cartilage defects. A high-signal interface between the lesion and the femur was used as evidence of lesion instability and was found in 15 lesions. One of these lesions was questionably stable at surgery; the remainder were unstable and partially attached. The other six patients had displaced fragments with large articular defects that were clearly visualized on the MR examinations. We conclude that MR imaging is useful in evaluating articular surface defects and lesion stability in patients with osteochondritis dissecans.

Entities:  

Mesh:

Year:  1990        PMID: 2117355     DOI: 10.2214/ajr.155.3.2117355

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  25 in total

Review 1.  The clinical utility and diagnostic performance of MRI for identification and classification of knee osteochondritis dissecans.

Authors:  Carmen E Quatman; Catherine C Quatman-Yates; Laura C Schmitt; Mark V Paterno
Journal:  J Bone Joint Surg Am       Date:  2012-06-06       Impact factor: 5.284

2.  Stability of osteochondral fragments of the femoral condyle: magnetic resonance imaging with histopathologic correlation in an animal model.

Authors:  G Adam; M Bühne; A Prescher; C Nolte-Ernsting; K Bohndorf; R W Günther
Journal:  Skeletal Radiol       Date:  1991       Impact factor: 2.199

Review 3.  A review of knowledge in osteochondritis dissecans: 123 years of minimal evolution from König to the ROCK study group.

Authors:  Eric W Edmonds; John Polousky
Journal:  Clin Orthop Relat Res       Date:  2013-04       Impact factor: 4.176

4.  A case of osteochondritis dissecans in rickets.

Authors:  Albert W Quan; Douglas P Beall; Emily R Berry; Justin Q Ly; Clifford F Sweet; Jon R Fish
Journal:  Emerg Radiol       Date:  2005-06

5.  Radiology rounds. Osteochondritis dissecans.

Authors:  M Margolis; M K McLennan
Journal:  Can Fam Physician       Date:  1995-06       Impact factor: 3.275

6.  Sports injuries in children--a radiological viewpoint.

Authors:  H Carty
Journal:  Arch Dis Child       Date:  1994-06       Impact factor: 3.791

7.  Surgical management of osteochondritis dissecans of the knee.

Authors:  Brandon J Erickson; Peter N Chalmers; Adam B Yanke; Brian J Cole
Journal:  Curr Rev Musculoskelet Med       Date:  2013-06

Review 8.  Osteochondritis dissecans of the elbow.

Authors:  Ryan W Churchill; Julianne Munoz; Christopher S Ahmad
Journal:  Curr Rev Musculoskelet Med       Date:  2016-06

9.  Juvenile Osteochondritis Dissecans: Cartilage T2 Mapping of Stable Medial Femoral Condyle Lesions.

Authors:  Jie C Nguyen; Fang Liu; Donna G Blankenbaker; Kaitlin M Woo; Richard Kijowski
Journal:  Radiology       Date:  2018-05-15       Impact factor: 11.105

10.  Does operative fixation of an osteochondritis dissecans loose body result in healing and long-term maintenance of knee function?

Authors:  Robert A Magnussen; James L Carey; Kurt P Spindler
Journal:  Am J Sports Med       Date:  2009-02-09       Impact factor: 6.202

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.